Henry Schein Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
9,561
10,371
10,630
11,572
12,462
13,202
Cost of Goods Sold (COGS) incl. D&A
6,905
7,460
7,617
8,345
9,062
9,607
Gross Income
2,656
2,911
3,012
3,226
3,399
3,595
SG&A Expense
1,979
2,196
2,243
2,409
2,540
2,702
EBIT
677
715
769
-
859
893
Unusual Expense
-
-
35
46
-
140
Non Operating Income/Expense
2
5
-
3
-
-
Interest Expense
28
24
26
32
54
79
Pretax Income
665
709
721
756
823
695
Income Tax
191
216
211
218
363
155
Equity in Affiliates
10
12
14
19
17
22
Consolidated Net Income
484
505
523
556
477
562
Net Income
444
466
479
507
424
536
Net Income After Extraordinaries
457
466
479
507
442
536
Net Income Available to Common
444
466
479
507
424
536
EPS (Basic)
2.47
2.72
2.85
3.10
2.57
3.49
Basic Shares Outstanding
172
169
166
162
157
153
EPS (Diluted)
2.46
2.72
2.85
3.10
2.57
3.49
Diluted Shares Outstanding
175
171
168
164
158
154
EBITDA
805
867
928
987
1,052
1,101
Non-Operating Interest Income
13
14
13
13
18
21
Minority Interest Expense
40
39
44
50
53
26

About Henry Schein

View Profile
Address
135 Duryea Road
Melville New York 11747
United States
Employees -
Website http://www.henryschein.com
Updated 07/08/2019
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.